This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Caughey, B. Articles by Baron, G. S. Search for Related Content PubMed PubMed Citation Articles by Caughey, B. Articles by Baron, G. S.

Inhibition of Protease-Resistant Prion Protein Accumulation In Vitro by Curcumin

Laboratory of Persistent Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rocky Mountain Laboratories, Hamilton, Montana 59840

Received 15 November 2002/ Accepted 3 February 2003

Inhibition of the accumulation of protease-resistant prion protein (PrP-res) is a prime strategy in the development of potential transmissible spongiform encephalopathy (TSE) therapeutics. Here we show that curcumin (diferoylmethane), a major component of the spice turmeric, potently inhibits PrP-res accumulation in scrapie agent-infected neuroblastoma cells (50% inhibitory concentration, 10 nM) and partially inhibits the cell-free conversion of PrP to PrP-res. In vivo studies showed that dietary administration of curcumin had no significant effect on the onset of scrapie in hamsters. Nonetheless, other studies have shown that curcumin is nontoxic and can penetrate the brain, properties that give curcumin advantages over inhibitors previously identified as potential prophylactic and/or therapeutic anti-TSE compounds.

This article has been cited by other articles:

• Riemer, C., Burwinkel, M., Schwarz, A., Gultner, S., Mok, S. W. F., Heise, I., Holtkamp, N., Baier, M. (2008). Evaluation of drugs for treatment of prion infections of the central nervous system. J. Gen. Virol. 89: 594-597 [Abstract] [Full Text]  
• Caughey, W. S., Priola, S. A., Kocisko, D. A., Raymond, L. D., Ward, A., Caughey, B. (2007). Cyclic Tetrapyrrole Sulfonation, Metals, and Oligomerization in Antiprion Activity. Antimicrob. Agents Chemother. 51: 3887-3894 [Abstract] [Full Text]  
• Trevitt, C. R, Collinge, J. (2006). A systematic review of prion therapeutics in experimental models. Brain 129: 2241-2265 [Abstract] [Full Text]  
• Raymond, G. J., Olsen, E. A., Lee, K. S., Raymond, L. D., Bryant, P. K. III, Baron, G. S., Caughey, W. S., Kocisko, D. A., McHolland, L. E., Favara, C., Langeveld, J. P. M., van Zijderveld, F. G., Mayer, R. T., Miller, M. W., Williams, E. S., Caughey, B. (2006). Inhibition of Protease-Resistant Prion Protein Formation in a Transformed Deer Cell Line Infected with Chronic Wasting Disease. J. Virol. 80: 596-604 [Abstract] [Full Text]  
• Glatzel, M., Stoeck, K., Seeger, H., Luhrs, T., Aguzzi, A. (2005). Human Prion Diseases: Molecular and Clinical Aspects. Arch Neurol 62: 545-552 [Abstract] [Full Text]  
• Aguzzi, A., Haass, C. (2003). Games Played by Rogue Proteins in Prion Disorders and Alzheimer's Disease. Science 302: 814-818 [Abstract] [Full Text]  
• Kocisko, D. A., Baron, G. S., Rubenstein, R., Chen, J., Kuizon, S., Caughey, B. (2003). New Inhibitors of Scrapie-Associated Prion Protein Formation in a Library of 2,000 Drugs and Natural Products. J. Virol. 77: 10288-10294 [Abstract] [Full Text]